|
|
Other links at Articles > Diabetes and Endocrinology |
| 3. |
New DDP-4 Inhibitor Shows Safety, Efficacy in Type 2 Diabetes
|
|
|
Almost half of patients with type 2 diabetes poorly controlled with diet and exercise or other antidiabetic agents were able to reach target hemoglobin A1C levels of less than 7.0% with a new, highly selective dipeptidyl peptidase-IV (DDP-4) inhibitor, alogliptin (SYR-32, Takeda Pharmaceutical Co.). Reuters Health Information
|
| 5. |
BMI and Weight Gain Unrelated to Colon Cancer Recurrence Risk
|
|
|
There is no apparent relationship between body mass index (BMI) or weight gain after treatment for colon cancer and recurrence or survival, US and Canadian researchers report in the September 1st issue of the Journal of Clinical Oncology. However, there is an indication of an increased risk of colon cancer recurrence in extremely overweight patients, the researchers add. Reuters Health Information
|
|
|